Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Nelli Erwin
Advertisement
Nelli Erwin is the head of protein stability for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
Articles by Nelli Erwin
Advertisement
Latest Updated Articles
- Seven Trends Shaping the Future of Pharmaceutical Formulation Development
Published: October 7th 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
2
PharmTech Weekly News Roundup – Week of November 3, 2025
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development
5
